Newsroom

Press Release - All

• 27 May 2022
  Agilent Announces Collaboration with APC on Real-Time Process Monitoring
• 24 May 2022
  Agilent Reports Second-Quarter Fiscal Year 2022 Financial Results
• 18 May 2022
  Agilent Announces Cash Dividend of 21 Cents per Share
• 10 May 2022
  Agilent Companion Diagnostic Expands CE-IVD Mark in Europe to Include Cervical Cancer
• 26 Apr 2022
  Agilent to Announce Second-Quarter Fiscal Year 2022 Financial Results May 24
• 19 Apr 2022
  Agilent Joins the National Institute for Innovation in Manufacturing to Advance Biomanufacturing
• 18 Apr 2022
  Agilent Listed in Singapore Employers Top 200 Ranking
• 08 Apr 2022
  Agilent Highlights Genomics and Cell Analysis Solutions for Cancer Research at AACR 2022
• 05 Apr 2022
  Agilent Companion Diagnostic Expands CE-IVD Mark for PD-L1 IHC 28-8 pharmDx to Include Esophageal Squamous Cell Carcinoma
• 05 Apr 2022
  Agilent Companion Diagnostic Expands CE-IVD Mark for PD-L1 IHC 28-8 pharmDx to Include Muscle-Invasive Urothelial Carcinoma (MIUC)